Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.75, read 2026-11-07
Ethical does not pass the values gate
Price34.79 USD
Fair value57.00
Ethical score70.0/100
Value readUndervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-10-18Read Markdown31.87+9.2% to today Accumulation gives way to Markdown after a 16% slide in 2 weeks
2026-10-02Read Accumulation38.12-8.7% to today Markdown gives way to Accumulation after a 6% rise in 3 weeks
2026-09-08Read Markdown35.87-3.0% to today ✓Markup gives way to Markdown after a 10% slide in 10 weeks
2026-07-02Read Markup39.80-12.6% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Ouster, Inc. holds its Distribution at $34.79. Consolidating, no directional conviction, held for 20 days.
As held on the ledger · 2026-11-06
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 20 days
Price at the screen
$34.79
Valuation
N/A trailing · -268.32 forward price to earnings
Values screen
FAIL· score 70.0
Beta
3.49
The Workings
Five Screens, Shown in Full
Does not pass. Interest-bearing securities
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
4.89%
Below 33%
Interest-bearing debt is just 4.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
40.39%
Below 33%
Interest-bearing cash and securities are 40.4% of assets, above the one-third limit.
Fail
Receivables
27.23%
Below 49%
Money owed to the company is 27.2% of assets, under the 49% limit.
Pass
Revenue purity
5.60%
Below 5%
5.6% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Ouster,'s business is fine, but its cash and interest-bearing securities are about 40% of its assets, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when OUST's ethical verdict changes
Today OUST does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 6 Nov 2026: it trades at roughly a 39% discount to our $57.00 fair value, 55.90% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 39.0% discount to the base estimate.
Where our models see it going: fair-value estimate $57.00, with a range of $52.00 to $69.59, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Lidar Sensors Promise a Future Few Can Afford
Picture a robot or self-driving car needing sharp eyes to navigate the world. Ouster supplies those lidar sensors across industries from autos to infrastructure, and revenue is rising fast at 49 percent. Yet the business still burns cash at every turn, with margins at minus 30 percent and return on equity at minus 25 percent.
We pass despite the clean ethical screen and analyst targets sitting well above the current price. Forward earnings sit at a nonsensical negative 823 times, which tells you the market sees no profits on the horizon. Growth alone does not create value when losses stay this heavy and the moat remains unknown.
The real danger lies in execution risk and competition that could keep margins crushed for years. Peak revenue hopes often meet reality in hardware plays like this, leaving investors with a value trap dressed up as innovation.
Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
OUST trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-03Markdown$29.74+0.0%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 141%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it strong buy, with a mean price target of $42. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markdown$29.74+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 141%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it strong buy, with a mean price target of $42. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markdown$29.74+0.2%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 141%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it strong buy, with a mean price target of $42. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Markdown$29.69+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 141%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it strong buy, with a mean price target of $42. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Markdown$29.69+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 141%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it strong buy, with a mean price target of $42. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Markdown$29.69-2.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 141%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it strong buy, with a mean price target of $42. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markdown$30.31+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 141%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it strong buy, with a mean price target of $42. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markdown$30.31+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 141%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it strong buy, with a mean price target of $42. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$30.31-4.9%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 1% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 141%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it strong buy, with a mean price target of $42. Insiders have been net sellers over the past quarter.
2026-10-18Markdown · changed$31.87-16.4%Entry 7
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 16.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are up 141%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it strong buy, with a mean price target of $42. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
